Concepedia

Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients

Jordi Río, Carlos Nos, Mar Tintoré, Nieves Téllez, Ingrid Galán, Raúl Pelayo, Manuel Comabella, Xavier Montalbán

Annals of Neurology · 2006 · 320 citations · 26 references

DOI

Abstract

Criteria of response to IFN-beta therapy in RRMS using disability progression are more clinically relevant than those based only in relapse rate. This finding may be important for the counseling and care of RRMS patients treated with IFN-beta.

References

26

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

Claudia F. Lucchinetti, Wolfgang Br�ck, Joseph E. Parisi et al. · Annals of Neurology · 2000 · 3.3K citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Lawrence Jacobs, Diane L. Cookfair, Richard A. Rudick et al. · Annals of Neurology · 1996 · 2.4K citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

George C. Ebers · The Lancet · 1998 · 2.1K citations

, , +9

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text